EarningsQ3 2022 Earnings Report

Vertex Pharmaceuticals (VRTX) Q3 2022 Earnings Report

0 Followers

MX:VRTX Q3 2022 EPS Results

Actual EPS$69.09

Consensus EPS$62.25

Beat/MissBeat by +$6.84

One Year Ago EPS$61.33

Actual Revenue$39.09B

Expected Revenue$38.42B

Beat/MissBeat by +$673.32M

YoY Revenue Growth+14.06%

QuarterQ3 2022

Date10/27/2022

TimeAfter Close

Conference CallThursday, October 27, 2022

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

MX:VRTX Q3 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	82.18 / -	82.699	―
Aug 03, 2026	2026 (Q2)	81.68 / 81.49	77.875	4.65% (+3.62)
May 04, 2026	2026 (Q1)	73.10 / 77.01	69.949	10.10% (+7.06)
Feb 12, 2026	2025 (Q4)	88.06 / 86.66	68.571	26.38% (+18.09)
Nov 03, 2025	2025 (Q3)	78.79 / 82.70	75.463	9.59% (+7.24)
Aug 06, 2025	2025 (Q2)	73.88 / 77.87	-221.047	135.23% (+298.92)
May 05, 2025	2025 (Q1)	74.38 / 69.95	82.01	-14.71% (-12.06)
Feb 10, 2025	2024 (Q4)	69.19 / 68.57	72.361	-5.24% (-3.79)
Nov 04, 2024	2024 (Q3)	70.26 / 75.46	70.294	7.35% (+5.17)
Aug 01, 2024	2024 (Q2)	-200.30 / -221.05	67.02	-429.82% (-288.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed